Tissue Engineering Market Research, 2027
The global tissue engineering market size was valued at $2,374 million in 2019, and is projected to reach $6,815 million by 2027, registering a CAGR of 14.2% from 2020 to 2027. Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore, maintain, or improve tissue function. To do this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs.
Increase in prevalence of chronic diseases & trauma emergencies, rise in awareness related to tissue engineering, technological advancements in 3D bio-printing ,and potential pipeline products drive the market growth. Furthermore, growth in number of R&D activities with rise in awareness of tissue engineering in emerging economies are expected to support the market growth. In addition, increase in focus of key players on tissue engineering based therapies are expected to enhance the tissue engineering market growth during the forecast period. However, stringent government regulations and high cost of treatment are estimated to hamper growth of the market.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Healthcare industries have been largely impacted by COVID-19 pandemic. After the COVID?19 pandemic, clinical research in tissue engineering are made unavailable and non?COVID?19 clinical trials are significantly reduced. Meanwhile, many of pharmaceutical and biotech companies have shifted their focus on development of drugs and vaccines for treatment of COVID?19. In addition, significant reduction in cell and tissue donation programs negatively impact growth of the tissue engineering market. Thus, delay & disruptions in clinical research and cancelations or delays in tissue replacement & reconstructive surgeries impend the tissue engineering market growth.
Tissue Engineering Market Segmentation
The global tissue engineering market is segmented into type, application, and region. On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold material segment is further categorized into synthetic polymer and others. The biologically derived scaffold material segment is sub segmented into collagen and others. On the basis of application, the market is segregated into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Type Segment Review
On the basis of type, the market is categorized into synthetic scaffold material, biologically derived scaffold material, and others. The synthetic scaffold materials segment is expected to grow significantly, owing to its efficiency over other naturally derived materials. Synthetic materials are preferred over other materials as they provide a better outcome. Presently, the biologically derived materials segment is major revenue contributor in the tissue engineering market, owing to its properties such as biocompatibility, non-toxicity, biodegradability, good cell recognition properties, and easy functionalization.
By Type
Biologically Derived Scaffold Material segment holds a dominant position in 2019 and would continue to maintain the lead over the forecast period.
Application Segment Review
On the basis of application, the market is categorized into orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental, and others. The tissue engineering market for orthopedics & musculoskeletal application is expected to witness significant growth, owing to rise in adoption of tissue engineered products for orthopedics & musculoskeletal applications, rise in commercialization for bone and cartilage repair tissue engineered products, wide availability of products, and rise in incidences of musculoskeletal disorders with increase in awareness of tissue engineered products. It is estimated the cardiovascular segment would show the highest market growth, owing to rise in incidences of cardiovascular diseases and surge in R&D activities to develop tissue engineered products for cardiology.
By Application
Cardiovascular is projected as one of the most lucrative segment.
Snapshot of Asia-Pacific Tissue Engineering Market
Asia-Pacific presents lucrative opportunities for key players operating in the tissue engineering market, owing to its growth in awareness regarding tissue engineered products, rise in demand for advanced healthcare services in emerging economies, developing R&D sector, and rise in presence of key players in the region. Furthermore, developing healthcare infrastructure and increase in focus on regenerative medicine has led to rapid developments in the market.
By Region
Asia-Pacific region would exhibit the highest CAGR of 14.2% during 2019-2026.
Competitive Analysis
The key players profiled in this report include AbbVie Inc. (Allergen Plc.), B. Braun Melsungen AG, Becton, Dickinson and Company (C. R. BARD, INC.), Integra LifeSciences, Organogenesis Holdings, Sid Martin Biotech (Axogen), Smith & Nephew Plc. (Osiris Therapeutics), TissueTech Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc.
Key Benefits For Stakeholders
- The study provides an in-depth analysis of the tissue engineering market size along with current trends and future estimations to elucidate the imminent investment pockets.
- It offers tissue engineering market analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global tissue engineering market growth.
Tissue Engineering Market Report Highlights
| Aspects | Details |
 By Type |
|
 By Application |
|
 By Region |
|
 Key Market Players | TISSUETECH INC., SMITH & NEPHEW PLC. (OSIRIS THERAPEUTICS), INTEGRA LIFESCIENCES, ABBVIE INC. (ALLERGEN PLC.), B. BRAUN MELSUNGEN AG, ZIMMER BIOMET HOLDINGS, INC., VERICEL CORPORATION, ORGANOGENESIS HOLDINGS, SID MARTIN BIOTECH (AXOGEN), BECTON, DICKINSON AND COMPANY (C. R. BARD, INC.) |
Analyst Review
Tissue engineering is an interdisciplinary field that applies principles of engineering and life sciences toward development of biological substitutes that restore or improve tissue function. Tissue engineering involves use of a tissue scaffold for formation of new viable tissues for medical purposes. Tissue engineering is applicable for various indications such as orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, and dental.
Increase in patient awareness toward tissue engineering, increase in prevalence of trauma injuries, technological advancements in the field of 3D tissue engineering, and higher number of R&D activities to develop ideal tissue engineered products drive growth of the tissue engineering market. However, stringent regulations and higher cost hinder the growth of the market.
North America is expected to remain dominant during the forecast period, owing to higher adoption of these products, ease of accessibility, and presence of major key players along with R&D centers fuel the market growth. Moreover, Asia-Pacific and LAMEA are expected to offer lucrative opportunities to key players during the forecast period, owing to increase in patient awareness toward tissue engineering with rise in penetration of key players in the emerging countries in Asia-Pacific.
The total market value of Tissue Engineering market is $2,374 million in 2019.
The forcast period for Tissue Engineering market is 2020 to 2027
The market value of Tissue Engineering market in 2020 is $2,688 million.
The base year is 2019 in Tissue Engineering market
Top companies such as AbbVie Inc. (Allergen Plc.), Smith & Nephew Plc. (Osiris Therapeutics), Integra LifeSciences and others. These key players held a high market postion owing to the strong geographical foothold in different regions.
Biologically derived Scaffold Material segment most influencing segment in market, owing to its properties such as biocompatibility, non toxicicty, biodegradability, good cell recognition properties, easy functionalization and others are majorly drives the market growth of this segment
The major factors that drive the global Tissue Engineering market include rise in awareness related to tissue engineering, technological advancement in 3D bio-printing and potential pipeline products will drive the market growth.
Asia-Pacific has the highest growth rate 16.3% in the market which is growing due to growth in awareness about tissue engineered products, rise in demand of advanced healthcare services in the emerging economies, developing R&D sector, and rise in presence of key players in this region influence the market growth.
Tissue engineering is an interdisciplinary field that applies the principles of engineering and life sciences toward the development of biological substitutes that restore, maintain, or improve tissue function. To do this process, cells and biomolecules are combined with scaffolds. Scaffold is an artificial or natural structure that mimics real organs
Tissue Engineering product use for different application areas such as orthopedics & musculoskeletal, neurology, cardiovascular, skin & integumentary, dental and others
Loading Table Of Content...
